Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

NCT00003861 ·Status: ACTIVE_NOT_RECRUITING

Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence

NCT05310591 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

NCT02783651 ·Status: COMPLETED

Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT01185886 ·Status: UNKNOWN

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

NCT00449761 ·Status: TERMINATED ·Phase: PHASE2

First Report, Five Years Experience of the Acute Leukemia Work Group

NCT02990104 ·Status: UNKNOWN

Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia

NCT01438138 ·Status: COMPLETED

Phase III B in Acute Lymphoblastic Leukemia

NCT03123939 ·Status: COMPLETED ·Phase: PHASE3

Latin American Real-world Study in Acute Leukemia

NCT05166135 ·Status: COMPLETED

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

NCT01533168 ·Status: COMPLETED

Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia

NCT01642121 ·Status: COMPLETED

A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL)

NCT01035216 ·Status: TERMINATED ·Phase: PHASE1

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

NCT02167360 ·Status: WITHDRAWN ·Phase: PHASE2

Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia

NCT01540578 ·Status: COMPLETED

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

NCT06137118 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia

NCT03628053 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy

NCT03298516 ·Status: COMPLETED ·Phase: PHASE1

Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia

NCT00898092 ·Status: UNKNOWN

Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

NCT01408160 ·Status: TERMINATED ·Phase: PHASE1

AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00321724 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

NCT03751072 ·Status: COMPLETED

Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia

NCT03367299 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Acute Myeloblastic Leukemia in Younger Patients

NCT00390715 ·Status: COMPLETED

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

NCT03876769 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

NCT01670084 ·Status: WITHDRAWN ·Phase: PHASE2